Biotech trends driving the deals of 2025

Emma Dorey
Biopharma Dealmakers · Springer Nature · 2025-12-01 · DOI: 10.1038/d43747-025-00113-2

Abstract

Biopharma Dealmakers, Published online: 01 December 2025; doi:10.1038/d43747-025-00113-2 This year’s drug development has been characterized by multiple deals signed with companies from China, along with collaborations involving firms specializing in artificial intelligence and antibodies.

Read at publisher →

Similar articles